Debut Plus

174.79

+3.12 +1.82%

17 Jul 2026

NSE Listed · Pharmaceuticals

Piramal Pharma Limited (PPLPHARMA)

Volume: 4,87,508Avg Vol 1W: 15,40,793Avg Vol 1M: 42,02,21152W Range:132.3220.85
Market Cap₹23,271 Cr
Current Price₹174.79
Previous Close₹171.67
High / Low (52w)₹220.85 / ₹132.3
Volume4,87,508
Avg Vol (1W)15,40,793
Avg Vol (1M)42,02,211
Stock P/E
Book Value₹61.34
Dividend Yield0%
ROE-357.62%
ROA-181.43%
Revenue (TTM)
Revenue Growth11.99%
Profit Margin-367.5%
Total Debt₹3,214 Cr
Shares Outstanding133 Cr
Face Value₹10
EPS (TTM)₹0
P/B2.85
Debt / Equity0.7
50 DMA₹168.67
200 DMA₹161.02
Day change+1.82%
Price Chart
174.79 7.21% · 1Y
1981339.3Cr
2025-11-21
2026-07-16

20-day avg volume: 43.8L shares

Pros
  • Company is almost debt-free.
Cons
  • Company is loss-making at the latest annual result.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹1,951 Cr₹2,242 Cr₹2,204 Cr₹2,754 Cr₹1,934 Cr₹2,044 Cr₹2,140 Cr₹2,752 Cr
EBITDA₹39 Cr₹211 Cr₹153 Cr₹360 Cr₹-32 Cr₹21 Cr₹26 Cr₹288 Cr
Net Profit₹-89 Cr₹23 Cr₹4 Cr₹154 Cr₹-82 Cr₹-99 Cr₹-136 Cr₹-9 Cr
EPS
Profit & Loss (Annual)
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue₹6,479 Cr₹6,835 Cr₹7,307 Cr₹8,347 Cr₹9,286 Cr₹9,082 Cr
EBITDA₹1,047 Cr₹639 Cr₹177 Cr₹631 Cr₹763 Cr₹304 Cr
Net Profit₹835 Cr₹376 Cr₹-186 Cr₹18 Cr₹91 Cr₹-326 Cr
EPS13.33.19-1.540.140.68-2.46
Balance Sheet
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹10,900 Cr₹12,797 Cr₹14,523 Cr₹15,312 Cr₹15,678 Cr₹17,965 Cr
Total Liabilities₹5,295 Cr₹6,100 Cr₹7,749 Cr₹7,400 Cr₹7,552 Cr₹9,802 Cr
Equity₹5,605 Cr₹6,697 Cr₹6,774 Cr₹7,911 Cr₹8,125 Cr₹8,163 Cr
Total Debt
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹742 Cr₹936 Cr₹673 Cr₹1,161 Cr₹1,227 Cr₹1,863 Cr
Investing₹-4,480 Cr₹-1,812 Cr₹-1,339 Cr₹-434 Cr₹-477 Cr₹-826 Cr
Financing₹3,977 Cr₹794 Cr₹818 Cr₹-422 Cr₹-441 Cr₹-39 Cr
Free Cash Flow₹742 Cr₹936 Cr₹673 Cr₹1,161 Cr₹1,227 Cr₹1,863 Cr
Shareholding
Promoter 34.86% Institutions 45.79% Public 19.35%
Efficiency & Working Capital
ROCE2.6%
Interest Coverage1
Dividend Payout
Debtor Days89 d
Inventory Days126 d
Payable Days102 d
Cash Conversion Cycle113 d
Working Capital Days215 d
Shareholding Details

As of 2026-03-31

Promoter34.9%
FII30.2%
DII15.6%
Institutions45.8%
Public19.4%
Promoter Pledge0%
No. of Shareholders4,50,661
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodAug 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Promoters35%35%35%35%34.9%34.9%34.9%34.9%34.9%34.9%34.9%34.9%
FIIs32.2%32.4%32.5%30.6%31.4%31.7%31.7%31.5%30.9%30.3%29.7%30.2%
DIIs7.8%8%9.7%12.1%13%13.8%14.1%14.8%14.3%14.9%15.7%15.6%
Public24.9%24.6%22.8%22.3%20.7%19.5%19.3%18.8%20%20%19.8%19.4%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders2,95,7733,00,6062,92,3122,97,9963,06,3983,59,7514,18,4424,32,8434,58,4304,62,5114,53,8304,50,661
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603
Major Shareholders (>1%)
NameCategoryStakeShares
The Sri Krishna Trust Through Its Trustee Mr. Ajay G Piramal And Dr. (mrs.) Swati A PiramalShareholding of Promoter and Promoter Group26.6%35.29 Cr
Ca Alchemy InvestmentsPublic Shareholding18%23.87 Cr
Hdfc Trustee Company Limited-hdfc Flexi Cap FundPublic Shareholding9.4%12.46 Cr
V3 Designs LlpShareholding of Promoter and Promoter Group3.2%4.30 Cr
Prl Realtors LlpShareholding of Promoter and Promoter Group3%3.98 Cr
East Bridge Capital Master Fund I LtdPublic Shareholding2%2.66 Cr
Indiahold LimitedPublic Shareholding1.3%1.73 Cr
Canara Robeco Mutual Fund A/c Canara Robeco Small Cap FundPublic Shareholding1%1.33 Cr
Piramal Welfare TrustShareholding of Promoter and Promoter Group0.8%1.06 Cr
Semplice Corporate Solutions Private Limited (formerly Known As Aasan Corporate Solutions Private LiShareholding of Promoter and Promoter Group0.7%89,31,097
The Ajay G. Piramal FoundationShareholding of Promoter and Promoter Group0.3%43,75,937
Mr. Anand PiramalShareholding of Promoter and Promoter Group0.1%8,74,082
Anand Piramal TrustShareholding of Promoter and Promoter Group0.1%6,17,884
Mr. Ajay G. PiramalShareholding of Promoter and Promoter Group0%5,47,326
Nandini Piramal TrustShareholding of Promoter and Promoter Group0%5,44,325
Mr. Peter DeyoungShareholding of Promoter and Promoter Group0%4,32,000
Ms. Nandini PiramalShareholding of Promoter and Promoter Group0%2,90,418
Ms. Anya Piramal DeyoungShareholding of Promoter and Promoter Group0%1,92,000
Master Dev Piramal DeyoungShareholding of Promoter and Promoter Group0%1,92,000
Mr. Ajay G. Piramal (karta Of Ajay G. Piramal Huf)Shareholding of Promoter and Promoter Group0%28,857
Late Mrs. Lalita G. PiramalShareholding of Promoter and Promoter Group0%4,936
Dr. (mrs.) Swati A. PiramalShareholding of Promoter and Promoter Group0%9,313
Piramal Corporate & Management Services Pvt. Ltd.Shareholding of Promoter and Promoter Group0%0
Anutham Realty Private LimitedShareholding of Promoter and Promoter Group0%0
Swati Piramal TrustShareholding of Promoter and Promoter Group0%0
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Mr. Ajay G. Piramal00%2026-03-31
Dr. (mrs.) Swati A. Piramal00%2026-03-31
Mr. Anand Piramal00%2026-03-31
Ms. Nandini Piramal00%2026-03-31
Late Mrs. Lalita G. Piramal00%2026-03-31
Mr. Peter Deyoung00%2026-03-31
Ms. Anya Piramal Deyoung00%2026-03-31
Master Dev Piramal Deyoung00%2026-03-31
Mr. Ajay G. Piramal (karta Of Ajay G. Piramal Huf)00%2026-03-31
Semplice Corporate Solutions Private Limited (formerly Known As Aasan Corporate Solutions Private Li00%2026-03-31
Prl Realtors Llp00%2026-03-31
The Ajay G. Piramal Foundation00%2026-03-31
Board of Directors
NameDesignationYear
Nandini PiramalChairperson / Executive Director2026
PETER D DEYOUNGExecutive Director & CEO2026
Vivek ValsarajExecutive Director & CFO2026
Nathalie LeitchIndependent Non Exe. Director2026
Amit JainNon-Exec & Non-Independent Dir2026
Jairaj Manohar PurandareIndependent Non Exe. Director2026
Sridhar GorthiIndependent Non Exe. Director2026
Peter StevensonIndependent Non Exe. Director2026
Vibha Paul RishiIndependent Non Exe. Director2026
AMIT SONIIndependent Non Exe. Director2026
Maneesh SharmaCompany Sec. & Compli. Officer2026
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹102,6291,3271,327
Corporate Actions
TypeDateValueRemark
dividend2025-07-16₹0.14 (1.4%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202611,0111540265011,241
20262,564000502,614
20267,7301802607,774
Substantial Acquisitions (SAST)

6 disclosure(s)

Market26/06/2025 · 2,65,48,576
Market29/07/2024 · 2,72,82,116
Creation Of Encumbrance28/05/2024 ·
Market14/03/2024 · 8,20,662
Creation Of Encumbrance11/03/2024 ·
Encumbrance Created22/02/2024 ·
Company Information
Incorporated2020
ChairmanNandini Piramal
AuditorSuresh Surana & Associates LLP
Investor Email[email protected]
🌐 www.piramalpharma.com

📍 Ananta Bldg Piramal Corporate, Park LBS Marg Kurla west, Mumbai, Maharashtra, 400070

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search